2227029-18-5

2227029-18-5 structure
2227029-18-5 structure
  • Name: TUS-007
  • Chemical Name: TUS-007
  • CAS Number: 2227029-18-5
  • Molecular Formula: C44H54Cl2N8O5
  • Molecular Weight: 845.86
  • Catalog: Signaling Pathways GPCR/G Protein Ras
  • Create Date: 2023-04-12 18:38:28
  • Modify Date: 2024-04-07 10:03:36
  • TUS-007 is a CANDDY molecular, modified from a proteasome inhibitor. However, TUS-007 hardly inhibits proteasome activity. TUS-007 is also an orally active and potent KRAS G12D/V degrader. TUS-007 can be applied in KRAS G12D/V chemical knockdown in cell-free. TUS-007 also exhibits tumor suppression[1]. Note: CANDDY refers to Chemical knockdown with Affinity aNd Degradation DYnamics.

Name TUS-007
Description TUS-007 is a CANDDY molecular, modified from a proteasome inhibitor. However, TUS-007 hardly inhibits proteasome activity. TUS-007 is also an orally active and potent KRAS G12D/V degrader. TUS-007 can be applied in KRAS G12D/V chemical knockdown in cell-free. TUS-007 also exhibits tumor suppression[1]. Note: CANDDY refers to Chemical knockdown with Affinity aNd Degradation DYnamics.
Related Catalog
Target

KRas G12D

KRas G12V

In Vitro TUS-007 具有显著的靶向作用,对表达 KRAS G12D/V 的细胞具有毒性[1]。 TUS-007 (100 μM; 72 h) 选择性地降低表达 KRAS G12D/V 的低 RAS 小鼠胚胎成纤维细胞 (MEF) 的活力,而不是影响 KRAS G12C[1]。 TUS-007 (20-160 μM; 72 h) 可增加 annexin V 阳性的 SW1990 细胞的凋亡比例[1]。 Apoptosis Analysis[1] Cell Line: SW1990 cells Concentration: 20 μM, 40 μM, 80 μM, and 60 μM Incubation Time: 72 hours Result: Increased the proportion of annexin V-positive apoptotic SW1990 cells compared with those treated with DMSO or RAS-SOS-NH2.
In Vivo TUS-007 (80 mg/kg 腹腔注射或 160 mg/kg 口服;每 3 天 1 次,共 21 天) 在 SW620-Luc 异种移植小鼠模型中,对 KRAS G12V 驱动的肿瘤在体内有抑制效力[1]。 TUS-007 即使在原位异种移植模型小鼠中也具有抗肿瘤活性[1]。 Animal Model: Immunodeficient mice bearing SW620-Luc cells[1] Dosage: 80 mg/kg or 160 mg/kg Administration: Intraperitoneal injection or oral gavage; once every 3 days for 21 days Result: Significantly attenuated tumor progression without affecting body weight.
References

[1]. Imanishi S, et al. In vivo KRAS G12D/V degradation mediated by CANDDY using a modified proteasome inhibitor. bioRxiv, 2021: 2021.04. 23.441075.

Molecular Formula C44H54Cl2N8O5
Molecular Weight 845.86
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.